I'm not aware of good evidence and there's plenty of evidence about harms/waste in screening.
I'd rather argue that resource is invested in supporting smokers to quit. In many low and middle income countries there is insufficient training of healthcare workers in Very Brief Advice and limited access to affordable pharmacotherapy (nicotine replacement therapy and/or cytisine and/or varenicline). Shouldn't we aim to support implementation of one thing well and comprehensively, rather than five things poorly?
HIFA profile: Sian Williams is Executive Officer at the International Primary Care Respiratory Group in the UK. Professional interests: Implementation science, NCDs, primary care, respiratory health, education, evaluation, value, breaking down silos. sian.health AT gmail.com